Clinical Trial Imaging Market Worth US$ 981 Million by 2020

New York, April 24: Market Research Engine has published a new report titled as “Clinical Trial Imaging Market By Product Segment Analysis (Software, Service, System and technology, Reader service, Operational imaging services, Design consulting); By Modality Analysis (X ray, PET, CT, MRI, Ultrasound, Echo); By End-user Analysis (Academic and government research institutes, Medical devices manufacturers, Biopharmaceutical companies, CROs) and By Regional Analysis – Global Forecast by 2016 - 2022”

How Big is the Global Clinical Trial Imaging Market?

The Clinical Trial Imaging Market is Expected to Exceed more than US$ 981 Million by 2020.

Browse Full Report: https://www.marketresearchengine.com/clinical-trial-imaging-market

Clinical imaging is essential element of the expensive research and development method of biotechnology and pharmaceutical industries. The usage of medical imaging is established in clinical trials, for making trials more accurate and effective. Clinical trial imaging brings information of human physiology /anatomy, changeable from incontestable interpretable information to information which is of uncertain value. The image presenting long fractured bone is basically understood rather than a sharing of uncharacterized ligand receptor in cerebral cortex is meaningless. The clinical assumptions of an image are essential in evaluating the medicine effect. Clinical imaging is used on daily base to manage, prevent, treat, detect, and various diseases or medical conditions.

The major driving factors of global clinical trial imaging market are as follows:

• Rise in R&D spending
• Rising number of cros
• Development in the biotechnology and pharmaceutical Industries

The restraining factors of global clinical trial imaging market are as follows:

• High implementation charge of imaging systems

The Global clinical trial imaging market is segmented on the lines of itsproducts, modality, end users and regional. The products are further segmented into software and services. Based on services segmentation it covers into system and technology, reader service, operational imaging services and design consulting. The modality market is classified intoX ray, PET, CT, MRI, ultrasound, echo and others. The CT has the main share in the clinical trial imaging market. End users segmented into academic and government research institutes, medical devices manufacturers, biopharmaceutical companies, CROs and others. Theclinical trial imaging market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for global clinical trial imaging market and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for global clinical trial imaging market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets Global clinical trial imaging market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BioClinica Inc, Cardiovascular Imaging Technologies, ICON plc, Biomedical Systems, Intrinsic Imaging LLC, PAREXEL International Corporation, VirtualScopic Inc and Prism Clinical Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Clinical trial imaging Market has been segmented as below:

By Product Segment Analysis

• Software
• Service
• System and technology
• Reader service
• Operational imaging services
• Design consulting.
•
By Modality Analysis

• X ray
• PET
• CT
• MRI
• Ultrasound
• Echo
• Others
•
By End-user Analysis

• Academic and government research institutes
• Medical devices manufacturers
• Biopharmaceutical companies
• CROs
• Others

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all globalclinical trial imaging market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of global clinical trial imaging market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.